143 related articles for article (PubMed ID: 5104635)
1. The nucleic acid content of lymphocytes in thyrotoxicosis.
Smith JF; Glen AC; Greig WR
Clin Exp Immunol; 1971 Jun; 8(6):911-6. PubMed ID: 5104635
[TBL] [Abstract][Full Text] [Related]
2. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
Alford FP; Larkins RG; Martin FI
Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
[No Abstract] [Full Text] [Related]
3. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
[No Abstract] [Full Text] [Related]
4. [Thyrotoxicosis].
Nagata I
Naika Hokan; 1970 Dec; 17(12):459-77. PubMed ID: 4099951
[No Abstract] [Full Text] [Related]
5. [Clinical studies of long-acting thyroid stimulator].
Eguchi Y
Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
[No Abstract] [Full Text] [Related]
6. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine].
Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S
Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759
[No Abstract] [Full Text] [Related]
7. Combined carbimazole-131-I treatment for thyrotoxicosis.
McDougall IR; Greg WR
Scott Med J; 1972 Feb; 17(2):57-61. PubMed ID: 4111803
[No Abstract] [Full Text] [Related]
8. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
9. [The sialic acid content of the blood of thyrotoxicosis patients treated with radioiodine].
Udod VM; Kuz'mak NI
Med Radiol (Mosk); 1967 Apr; 12(4):45-8. PubMed ID: 6052183
[No Abstract] [Full Text] [Related]
10. [Para-neoplastic hyperthyroidism with elevated plasmatic T.S.H].
Codaccioni JL; Jaquet P
Ann Endocrinol (Paris); 1971; 52(4):553-6. PubMed ID: 5139434
[No Abstract] [Full Text] [Related]
11. Changes in the ankle jerk time during the course of radioiodine treatment of hyperthyroidism.
Zamrazil V; Vána S; Nĕmec J
Rev Fr Etud Clin Biol; 1969 Apr; 14(4):377-80. PubMed ID: 5804694
[No Abstract] [Full Text] [Related]
12. The long-acting thyroid stimulator.
Munro DS
Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
[No Abstract] [Full Text] [Related]
13. [Chronic thrombopenic purpura. Hyperthyroidism, pretibial myxedema and L.A.T.S].
Cattan D; Caen J; Fernandez Y; Izard J; Leclere H; Tanguy A; Lemenager J
Presse Med (1893); 1970 Jul; 78(35):1535-40. PubMed ID: 5464336
[No Abstract] [Full Text] [Related]
14. Effect of pretreatment with carbimazole in patients with thyrotoxicosis subsequently treated with radioactive iodine.
Goolden AW; Fraser TR
Br Med J; 1969 Aug; 3(5668):443-4. PubMed ID: 4185887
[TBL] [Abstract][Full Text] [Related]
15. [Hematologic changes in the treatment of thyrotoxicosis and cancer of the thyroid gland with radioactive iodine 131-I].
Nĕmec J; Neradilová M; Zamrazil V; Vohnout S
Cas Lek Cesk; 1968 Jun; 107(25):742-8. PubMed ID: 5664846
[No Abstract] [Full Text] [Related]
16. Evaluation of the relationship between long-acting thyroid stimulator, clinical and biological thyrotoxicosis and exophthalmos.
Bonnyns M; Demeester-Mirkine N; Calay R; Bastenie PA
Acta Endocrinol (Copenh); 1968 Aug; 58(4):581-92. PubMed ID: 5695780
[No Abstract] [Full Text] [Related]
17. [Frequency of recurrence following treatment of hyperthyroidism with methimazole and suppressibility of the thyroid gland (author's transl)].
Hackenberg K; Reinwein D; Schemmel K
Munch Med Wochenschr; 1973 Dec; 115(49):2216-8. PubMed ID: 4205415
[No Abstract] [Full Text] [Related]
18. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
19. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
20. Dynamics of some haematological indicators following 131-I therapy in thyroid cancer and thyrotoxicosis.
Nĕmec J; Neradilová M; Zamrazil V; Vohnout S
Rev Czech Med; 1967; 13(1):16-29. PubMed ID: 6044707
[No Abstract] [Full Text] [Related]
[Next] [New Search]
